Pregnancy outcome following in utero exposure to ondansetron. Importantly, a recent large control study by the slone epidemiology center in boston, mass, and the centers for disease control and prevention in atlanta, ga, detected a 2fold increased risk of cleft palate associated with ondansetron taken for nvp in the first trimester of pregnancy odds ratio 2. Ondansetron use in early pregnancy and the risk of. It is not known whether ondansetron passes into breast milk or if it could harm a nursing baby. Treatment of nausea and vomiting in pregnancy australian. Ondansetron is a medication used to treat nausea and vomiting that may be caused by surgery, chemotherapy or radiation therapy. In a pharmacokinetic study of 16 epileptic patients maintained. Hyperemesis gravidarum is a more severe form of nausea and vomiting which occurs in less than 1% of pregnancies. This drug should be used during pregnancy only if clearly needed us au tga pregnancy category. In this registrybased historical cohort study, ondansetron exposure in pregnancy was not associated with significantly increased risks of spontaneous abortion, stillbirth, any major birth defect. Use of ondansetron during pregnancy and congenital malformations.
Ondansetron in pregnancy and risk of adverse fetal. Ondansetron is a substrate of cytochrome p450 cyp 3a4 primary metabolic pathway, 2d6, and 1a2, all of which are altered during pregnancy. Listing a study does not mean it has been evaluated by the u. More evidence that ondansetron is safe during pregnancy. How safe and effective is ondansetron for nausea and vomiting.
Study examines effects of taking ondansetron during first. Mostly, the patients in the study were able to use less zofran gradually. Recent epidemiological studies suggest exposure to ondansetron during the first trimester of pregnancy is associated with a small increased risk of the baby having a cleft lip andor cleft palate. Ondansetron use in early pregnancy and the risk of congenital. Most pregnant women experience some form of nausea and vomiting, and prevalence rates are as high as 50% to 80%.
In 1997, ondansetron was the subject of a metaanalysis case study published in the british medical journal. Two epidemiologic studies have suggested that ondansetron may increase the risk of birth defects 10, 11. Moreover, the lack of other, similar cohort studies precluded conducting a meta analysis to increase the sample size. Association of maternal firsttrimester ondansetron use with. The safety of ondansetron for nausea and vomiting of pregnancy. Importantly, a recent large control study by the slone epidemiology center in boston, mass, and the centers for disease control and prevention in atlanta, ga, detected a 2fold increased risk of cleft palate associated with ondansetron taken for nvp in the first trimester. The data source, study design, and analytic methods were the same as described in our previously published evaluation of oral ondansetron. Ondansetron use increased from webmd provides common contraindications for ondansetron hcl oral. This study, which included almost 90,000 firsttrimester ondansetron exposures, is the largest study of this issue and provides the most reassuring data. While some studies suggested no increase in birth defects in women who took ondansetron early in pregnancy, others suggested the.
May 05, 2020 mostly, the patients in the study were able to use less zofran gradually. Moreover, a recent casecontrol study suggested there was an increased risk of cleft palate associated with ondansetron. Inhaled isopropyl alcohol superior to oral ondansetron as an. Ondansetron blocks the actions of chemicals in the body that can trigger nausea and vomiting. Several studies have suggested that associations may exist between maternal ondansetron use and fetal orofacial clefts, specifically cleft palate alone.
At higher doses, there have been reports that ondansetron use might cause a heart rhythm problem called qt interval prolongation in the person taking ondansetron. Offlabel use of ondansetron in pregnancy in western australia. Ondansetron has also been prescribed during pregnancy to reduce symptoms of nausea and vomiting in pregnancy nvp. Researchers examined 84 trials, with 11,980 people receiving ondansetron, published between 1991 and september 1996. Two of the patients received ondansetron during two separate pregnancies. The management of nausea and vomiting of pregnancy and. New zealand datasheet 1 product name ondansetrondrla tablets. Ondansetron in pregnancy and risk of adverse fetal outcomes. Ondansetron in pregnancy and the risk of congenital.
Ondansetron is commonly prescribed for nausea during early pregnancy. Taking ondansetron during pregnancy does not appear to. Symptoms can be more severe in women carrying twins. Ondansetron is used to prevent nausea and vomiting that may be caused by surgery, cancer chemotherapy, or radiation treatment ondansetron may be used for purposes not listed in this medication guide. Evaluation of experimental animal studies does not indicate direct or indirect harmful effects with respect to the development of the embryo, or foetus, the course of gestation and peri and. They felt better within a period of three to five days after chemotherapy, as compared to taking zofran alone. A study from the slone epidemiology center at boston university, in collaboration with the centers for disease control and prevention cdc, found that taking ondansetron during early pregnancy did not appear to increase the chance of having a baby with a birth defect. The nonpsychoactive cannabinoid cbd interacts with serotonin release receptors and has been shown to help alleviate nausea and vomiting. Oct 24, 2019 ondansetron is not expected to harm an unborn baby.
Mar 09, 2018 mean nausea scores decreased by 30 mm in the alcohol ondansetron group, 32 mm in the alcoholplacebo group, and 9 mm in the saline ondansetron group. Cc0 public domain ondansetron zofran is commonly and. Study examines effects of taking ondansetron during first trimester of pregnancy 18 december 2018 credit. Ondansetron is a selective 5ht 3 serotonin antagonist used in the treatment of chemotherapyinduced and postoperative nausea and vomiting, and offlicence for nausea and vomiting in pregnancy nvp and hyperemesis gravidarum hg. A third study found no association overall 12 but lacked power to examine individual birth defects. Antiemetic efficacy of ondansetron versus metoclopramide the safety and scientific validity of this study is the responsibility of the study sponsor and investigators. The study included all women giving birth in denmark between 1997. While fetal safety data for doxylaminepyridoxine are based on more than a quarter of a million pregnancies, the fetal safety data for ondansetron are based on fewer than 200 births. Dec 06, 2019 ondansetron is commonly prescribed for nausea during early pregnancy. Ondansetron is not approved for use by anyone younger than 4 years old.
Nausea and vomiting during pregnancy sometimes termed morning sickness are among the most common medical issue to arise during pregnancy. Therefore we conducted a nationwide cohort study testing the hypothesis use of ondansetron during the first trimester was associated with a higher prevalence of congenital malformations. The overall prevalences of ondansetron use among participants in the control group with firsttrimester nausea and vomiting of pregnancy were 3. Hg is the severe form of nvp, which affects about 0. The earliest study evaluating the safety of ondansetron in pregnancy was conducted by einarson et al. However, on the basis of available data, no dosage adjustment for ondansetron is recommended see. Only limited data concerning the safety of ondansetron in pregnancy is available. Ondansetron for treatment of nausea and vomiting of. The same authors repeated the analysis for intravenous exposures and found that intravenously administered ondansetron was not associated with an increase in the risk of cardiac malformations. Pdf ondansetron in pregnancy and risk of adverse fetal outcomes. We evaluated the pharmacokinetics of ondansetron at three different gestational time points in a 26. This is a descriptive retrospective case series of 14 pregnant women treated with ondansetron for hyperemesis gravidarum hg at chu saintejustine, from january 2002 to october 2011. Find out what health conditions may be a health risk when taken with ondansetron hcl oral.
The findings of these studies have been questioned, and the role of ondansetron in. Therefore we conducted a nationwide cohort study testing if use of ondansetron during the first trimester was associated with different subgroupings off malformations. Dec 02, 2015 antiemetic efficacy of ondansetron versus metoclopramide the safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Ondansetron use in the management of nausea and vomiting in pregnancy is common up to 15%. Antiemetic efficacy of ondansetron versus metoclopramide. Request pdf intravenous ondansetron in pregnancy and risk of congenital malformations a populationbased cohort study previously evaluated the association between firsttrimester exposure to. Animal studies have failed to reveal evidence of harm to the embryo, fetus, gestation period, perinatalpostnatal.
Ondansetron and risk of adverse fetal outcomes n engl j med 368. Ondansetron in pregnancy and the risk of congenital malformations. Intravenous ondansetron in pregnancy and risk of congenital. Both pregnancies were analyzed separately for the purposes of this study. Ondansetron exposure changes in a pregnant woman lemon. A cohort study showed no significant differences in pregnancy and fetal outcomes between 176 women who were exposed to ondansetron and 352 who were not exposed. How safe and effective is ondansetron for nausea and. Ondansetron for treatment of nausea and vomiting of pregnancy. Rescue antiemetic therapy was given to 28%, 25%, and 45% of each group, respectively. The safety of ondansetron for nausea and vomiting of. A 20 retrospective cohort study looked at 608,385 pregnancies among women in denmark, of whom 1970 0. The study included all women giving birth in denmark 1997 and 2010.
889 907 47 1338 1244 976 1053 144 1564 1279 1517 82 1062 1633 253 275 1375 715 914 417 1139 115 1283 1464 296 83 386 1391 620 727 1152 1100 903 965 1138 248 36 1460 1089 141 1371 1384 1107 552 38 152 1204 995 1096 119